NDC product
ergotamine tartrate and caffeine
NDC 24470-917 · Cintex Services, LLC
Key facts
| Product NDC | 24470-917 |
|---|---|
| Proprietary name | ergotamine tartrate and caffeine |
| Nonproprietary name | ergotamine tartrate and caffeine |
| Substances | ERGOTAMINE TARTRATE, CAFFEINE |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Labeler | Cintex Services, LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA040590 |
| Pharmacologic classes | Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Ergotamine Derivative [EPC], Ergotamines [CS], Methylxanthine [EPC], Xanthines [CS] |
| Marketing start | Nov 23, 2016 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: